Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

A Study of Sotorasib in People with Non-Small Cell Lung Cancer

Phase 2

Recruiting

Conditions: Non Small Lung Cancer

Interventions: Drug: Sotorasib

First Posted Date: 2024-09-03

Last Posted Date: 2024-11-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 39

Registration Number: NCT06582771

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

Phase 3

Recruiting

Conditions: HPV-Related Squamous Cell Carcinoma

Interventions: Diagnostic Test: FMISO-PET Scan
Combination Product: Chemoradiation
Other: Assessments

First Posted Date: 2024-08-20

Last Posted Date: 2025-03-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 291

Registration Number: NCT06563479

Locations: 🇺🇸
Hartford Healthcare (Data Collection Only), Hartford, Connecticut, United States
🇺🇸
Baptist Alliance MCI (Data Collection Only), Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States

and more 6 locations

A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People with Hairy Cell Leukemia (HCL)

Phase 2

Recruiting

Conditions: Hairy Cell Leukemia

Interventions: Drug: Vemurafenib
Drug: Cladribine
Drug: Obinutuzumab
Drug: Rituximab

First Posted Date: 2024-08-20

Last Posted Date: 2024-10-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 86

Registration Number: NCT06561360

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic Cancer Center, Rochester, Minnesota, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States

and more 7 locations

Registry for Esophageal and Gastroesophageal Junction Cancer

Recruiting

Conditions: Gastroesophageal-junction Cancer
Esophageal Cancer

Interventions: Other: EORTC QLQ-C30 questionnaire
Other: QLQ-OGS25 questionnaire

First Posted Date: 2024-08-19

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 50

Registration Number: NCT06558786

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

Recruiting

Conditions: Metastatic Breast Cancer
Breast Carcinoma
Metastatic Lobular Breast Carcinoma
Metastatic Breast Carcinoma
Breast Cancer
Lobular Breast Carcinoma

Interventions: Diagnostic Test: 18F-Fluoroestradiol PET/CT

First Posted Date: 2024-08-16

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT06557148

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale, New Jersey, United States

and more 4 locations

A Study of the BREAST-Q REACT Tool for People Having Breast Surgery

Not Applicable

Active, not recruiting

Conditions: Mastectomy With Reconstruction
Breast Conserving Surgery

Interventions: Other: QuickDASH
Other: BREAST-Q Physical Well-Being

First Posted Date: 2024-08-13

Last Posted Date: 2025-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 69

Registration Number: NCT06550401

Locations: 🇺🇸
Memorial Sloan Kettering at Basking Ridge (All Protocol Activities), Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Commack (All Protocol Activities), Commack, New York, United States

and more 3 locations

The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study

Recruiting

Conditions: Smoking, Cigarette
Tobacco Use
Tobacco Smoking
Smoking, Tobacco
Alcohol Drinking
Betel Chewer's Mucosa
Smoking
Smokeless Tobacco Hyperkeratosis

Interventions: Diagnostic Test: mHealth

First Posted Date: 2024-08-02

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 5122

Registration Number: NCT06535867

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center (All protocol activites), New York, New York, United States

Tislelizumab in People With Colorectal Cancer

Phase 2

Recruiting

Conditions: Colorectal Cancer

Interventions: Drug: Tislelizumab

First Posted Date: 2024-07-31

Last Posted Date: 2025-04-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 40

Registration Number: NCT06529523

Locations: 🇳🇬
Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇳🇬
Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Phase 2

Recruiting

Conditions: Neuroblastoma
Childhood Neuroblastoma
High-risk Neuroblastoma

Interventions: Biological: DANYELZA
Biological: Sargramostim
Drug: Cytoxan
Drug: Topotecan
Drug: Vincristine
Drug: Doxorubicin
Drug: Ifosfamide
Drug: Etoposide
Drug: Carboplatin
Drug: Irinotecan
Drug: Temozolomide

First Posted Date: 2024-07-30

Last Posted Date: 2025-05-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 45

Registration Number: NCT06528496

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

A Study of Radiation Therapy After Surgery in People with Oral Tongue Squamous Cell Carcinoma

Phase 2

Recruiting

Conditions: Oral Tongue Squamous Cell Carcinoma

Interventions: Radiation: Photon intensity modulated radiation therapy (IMRT)
Other: Life questionnaire's

First Posted Date: 2024-07-03

Last Posted Date: 2025-02-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 24

Registration Number: NCT06485778

Locations: 🇺🇸
Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States

and more 4 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy